Table 5 Total encounters of local staff by site stratified by meetings, site visits/training, and interviews

Meetings

 Monthly facilitation calls

63 (90%)

54 (84%)

23 (88%)

21 (91%)

48 (92%)

26 (93%)

31 (94%)

20 (95%)

286

 Cross-site collaboration calls

7 (10%)

10 (16%)

3 (12%)

2 (9%)

4 (8%)

2 (7%)

2 (6%)

1 (5%)

31

Meetings total

70

64

26

23

52

28

33

21

Site visits/trainings

 Advanced topics for waivered providers and difficult cases

4 (8%)

4 (16%)

22 (12%)

n/a

10 (9%)

13 (18%)

16 (12%)

9 (16%)

74

 Buprenorphine and naltrexone for the treatment of opioid use disorder (OUD)^a

n/a

n/a

n/a

12 (10%)

18 (16%)

12 (16%)

14 (10%)

11 (20%)

67

 Models for integrating OUD treatment into primary care and general mental health settings^a

n/a

n/a

24 (13%)

12 (10%)

18 (16%)

12 (16%)

20 (14%)

11 (20%)

97

 National efforts toward stepped care for OUD and available resources

n/a

n/a

n/a

n/a

n/a

n/a

27 (20%)

n/a

27

 National provider education and patient tracking resources, next steps, and wrap-up^a

13 (25%)

6 (24%)

24 (13%)

12 (10%)

18 (16%)

12 (16%)

11 (8%)

11 (20%)

107

 Project overview, site summary, and action plans^a

7 (14%)

3 (12%)

22 (12%)

27 (22%)

13 (12%)

13 (18%)

13 (9%)

9 (16%)

107

 Screening and treating OUD with a focus on buprenorphine and naltrexone

12 (24%)

n/a

n/a

12 (10%)

n/a

n/a

n/a

n/a

24

 Setting up a buprenorphine clinic

12 (24%)

n/a

24 (13%)

27 (22%)

18 (16%)

n/a

n/a

n/a

81

 What is addiction and how do we treat it?^a

n/a

7 (28%)

24 (13%)

n/a

n/a

n/a

37 (27%)

n/a

68

 X-waiver trainings

3 (6%)

5 (20%)

38 (21%)

22 (18%)

15 (14%)

11 (15%)

n/a

5 (9%)

99

Trainings total

51

25

178

124

110

73

138

56

Interviews

 Pre-site visit

9 (50%)

7 (50%)

8 (57%)

11 (61%)

7 (58%)

9 (69%)

8 (62%)

9 (75%)

68

 Post-site visit

9 (50%)

7 (50%)

6 (43%)

7 (39%)

5 (42%)

4 (31%)

5 (38%)

3 (25%)

46

Interviews total

18

14

14

18

12

13

13

12